On March 8, Nature’s Sunshine Product, Inc. (NASDAQ: NATR) announced its 2018 results.
In 2018, the revenue of NSP reached $ 365 million, up 6.67% year on year, and net profit loss $1.2 million, a decrease of 91.30% from the previous year's loss. Among them, NSP CHINA market revenue was $29.08 million, up 45.48% year on year, accounting for about 7.97% of the total revenue, an increase of about 3% over the previous year.
In terms of the performance distribution in China, the proportion of Digestive sector was 37.8%, which was down from the previous year, but was still much higher than that in other regions, including the US. Weight Management ranks the second place, contributing 17.0% to the performance, with an increase of about 1%. Personal Care sales contributed 10.3 percent of performance, in third place.
In the report, NSP said China's policies have a lot of uncertainties for the company's future development, including a crackdown on the direct-selling industry starting in December 2018 and the health food registration system.
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year
